Market Capitalization

With a promising cancer pipeline, Crescent Biopharma heads to key May conferences to prove its strategy against fierce competition in the bispecific and ADC markets.

The utility giant posted strong first-quarter earnings, driven by surging industrial demand, and reaffirmed its outlook amid a historic investment plan.

With $200 million in fresh capital, Quantum Leap Acquisition Corp. is hunting for a transformative company in the high-stakes world of deep technology.

Bill Ackman's ambitious Pershing Square USA fund saw a rocky NYSE launch, even as it drew high-profile global investors like Mexico's Jack Landsmanas.

While the broader housing market cools, Las Vegas's exclusive golf communities maintain their value. A new report offers a glimpse inside this resilient niche.

Singaporean engineering firm SKK Holdings pivots dramatically, acquiring Rantizo's drone assets to chase growth in agriculture and emergency response tech.

Facing steep losses, FG Nexus is exploring a merger with its CEO's other firm, a move into affordable housing that tests both strategy and shareholder trust.

With only 6% of sports science research focused on women, Gatorade's new 'Body of Science' initiative aims to finally close the critical knowledge gap.

As consumers tune out online ads, companies are rediscovering the power of human connection. Smart Circle's expansion signals a major shift back to face-to-face.

As Sachem Capital sets its Q1 earnings date, investors watch closely for signs of stability in the hard money lending market after a volatile period.

Following a year of record profits, Cipher Pharmaceuticals is renewing its share buyback program, signaling a strong belief that its stock is undervalued.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

Aimco declares a $1.30/share liquidating distribution. Understand the 'due bills' trading and what this means for your investment as the REIT winds down.

As Kodak prepares its Q1 2026 report, investors are watching to see if its pivot to advanced materials can sustain its recent market momentum.

The rail supplier's stellar Q2 results point to surprising strength in coal, rail, and tunneling, but rising costs reveal the challenges of rapid growth.

Singaporean oil trader Delixy Holdings faces a 180-day deadline to rescue its Nasdaq listing after its stock price collapsed, forcing tough choices.

Actor Terry Crews and 'Drive to Survive' creators team up for a new series taking fans inside the launch of the Cadillac Formula 1® team.

Over 200 zoo workers have authorized a strike, citing low wages and benefit cuts while the CEO's compensation soared. A Chicago icon faces shutdown.

A struggling HR tech firm is betting its future on a complex crypto trading strategy, linking profits to stock buybacks. Is it genius or desperation?

Backed by activist investor Irenic Capital, a new $220M blank-check firm hits Nasdaq, aiming to acquire a target in the aerospace or industrial sectors.